Recent advances in antiemetics: new formulations of 5HT(3)-receptor antagonists

PURPOSE: To discuss new therapeutic strategies for chemotherapy-induced nausea and vomiting (CINV) involving 5-hydroxytryptamine type 3 (5HT(3))-receptor antagonists (RAs). SUMMARY: CINV remains poorly controlled in patients receiving moderately emetogenic chemotherapy (MEC) or highly emetogenic che...

Descripción completa

Detalles Bibliográficos
Autores principales: Gilmore, James, D’Amato, Steven, Griffith, Niesha, Schwartzberg, Lee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037149/
https://www.ncbi.nlm.nih.gov/pubmed/30013391
http://dx.doi.org/10.2147/CMAR.S166912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037149/
https://www.ncbi.nlm.nih.gov/pubmed/30013391
http://dx.doi.org/10.2147/CMAR.S166912

Ejemplares similares